Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
E-pub ahead of print

Sertraline use during pregnancy and effect on fetal cardiac function

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Intravenous iron isomaltoside treatment of women suffering from severe fatigue after postpartum hemorrhage

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Prediction of preeclampsia in type 1 diabetes in early pregnancy by clinical predictors: a systematic review

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. E1. Risk of chronic hypertension in women with a history of hypertensive disorders of pregnancy - a nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Crown-rump length measurement error: impact on assessment of growth

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Kongenitte portosystemiske shunter, diagnose og behandling af en multisystemisk sygdom hos børn

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. National data on the early clinical use of non-invasive prenatal testing in public and private healthcare in Denmark 2013-2017

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Genetisk screening af kommende forældre

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

Vis graf over relationer

Objectives: The objective of this study was to evaluate the fetal cardiac function in human pregnancies exposed to sertraline (a selective serotonin reuptake inhibitor) compared to unexposed pregnancies.Method: We included 44 women in gestational week 25 + 0 days to week 26 + 6 days. Fifteen women used sertraline (50-150 mg per day), and 29 women used no daily medication. We assessed fetal cardiac function by Myocardial Performance Index (MPI), E/A ratios and by tricuspid and mitral annular plane systolic excursion (TAPSE and MAPSE) measured by 2D M-mode and by 4D eSTIC M-mode.Results: There were no differences between the sertraline exposed and the unexposed. The mean difference of MPI was 0.03 (95% CI -0.08-0.03), of tricuspid and mitral E/A ratios 0.00 (95% CI -0.03-0.05) and 0.03 (95% CI -0.07-0.01), respectively. The mean difference of TAPSE, by 2D and eSTIC, was 0.07 mm (95% CI -0.56-0.41) and 0.10 mm (95% CI -0.55-0.34). Mean difference of MAPSE, by 2D and eSTIC was 0.16 mm (95% CI -0.22-0.53) and 0.24 mm (95% CI -0.16-0.65), respectively. Serum levels of sertraline in exposed participants ranged from 33-266, median 92 nmol/L.Conclusions: We found no significant differences in fetal cardiac function, assessed by TAPSE, MAPSE, MPI and E/A ratios, in pregnancies exposed to sertraline compared to the unexposed.

OriginalsprogEngelsk
TidsskriftThe journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
Sider (fra-til)E-pub
ISSN1476-7058
DOI
StatusE-pub ahead of print - 12 nov. 2019
Eksternt udgivetJa

ID: 58968827